Nothing Special   »   [go: up one dir, main page]

PT65571B - Neue quartare n-beta-substituierte benzilsaure-n-alkyl-nortropinester und verfahren zu deren herstellung - Google Patents

Neue quartare n-beta-substituierte benzilsaure-n-alkyl-nortropinester und verfahren zu deren herstellung

Info

Publication number
PT65571B
PT65571B PT65571A PT6557176A PT65571B PT 65571 B PT65571 B PT 65571B PT 65571 A PT65571 A PT 65571A PT 6557176 A PT6557176 A PT 6557176A PT 65571 B PT65571 B PT 65571B
Authority
PT
Portugal
Prior art keywords
quartare
nortropinester
benzilsaure
beta
substituted
Prior art date
Application number
PT65571A
Other languages
German (de)
English (en)
Other versions
PT65571A (de
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of PT65571A publication Critical patent/PT65571A/pt
Publication of PT65571B publication Critical patent/PT65571B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06Oxygen atoms
    • C07D451/10Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PT65571A 1975-09-12 1976-09-10 Neue quartare n-beta-substituierte benzilsaure-n-alkyl-nortropinester und verfahren zu deren herstellung PT65571B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19752540633 DE2540633A1 (de) 1975-09-12 1975-09-12 Neue quartaere n-beta-substituierte benzilsaeure-n-alkyl-nortropinester und verfahren zu deren herstellung

Publications (2)

Publication Number Publication Date
PT65571A PT65571A (de) 1976-10-01
PT65571B true PT65571B (de) 1978-07-04

Family

ID=5956267

Family Applications (1)

Application Number Title Priority Date Filing Date
PT65571A PT65571B (de) 1975-09-12 1976-09-10 Neue quartare n-beta-substituierte benzilsaure-n-alkyl-nortropinester und verfahren zu deren herstellung

Country Status (22)

Country Link
US (1) US4042700A (pt)
JP (2) JPS5236693A (pt)
AT (1) AT353428B (pt)
AU (1) AU506286B2 (pt)
BE (1) BE846104A (pt)
CA (1) CA1079733A (pt)
CH (1) CH621349A5 (pt)
DE (1) DE2540633A1 (pt)
DK (1) DK142988C (pt)
ES (1) ES451467A1 (pt)
FI (1) FI62083C (pt)
FR (1) FR2323387A1 (pt)
GB (1) GB1517086A (pt)
IE (1) IE44166B1 (pt)
LU (1) LU75781A1 (pt)
MX (1) MX4053E (pt)
NL (1) NL187210C (pt)
NO (1) NO145199C (pt)
NZ (1) NZ182011A (pt)
PT (1) PT65571B (pt)
SE (1) SE428472B (pt)
ZA (1) ZA765426B (pt)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU174431B (hu) * 1976-12-08 1980-01-28 Egyt Gyogyszervegyeszeti Gyar Sposob poluchenija novykh proizvodnykh nortropin-carbazata
DE3320138A1 (de) * 1983-06-03 1984-12-06 Boehringer Ingelheim KG, 6507 Ingelheim Neues nortropinderivat, verfahren zu seiner herstellung und seine verwendung
DE4108393A1 (de) * 1991-03-15 1992-09-17 Boehringer Ingelheim Kg Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln
JPH0558911A (ja) * 1991-08-27 1993-03-09 N D Shinyaku Kaihatsu Kenkyusho:Kk 鎮咳去痰剤
US5770738A (en) * 1992-03-05 1998-06-23 Boehringer Ingelheim Kg Esters of bi- and tricyclic amino alcohols, their preparation and their use in pharmaceutical compositions
CZ20023537A3 (cs) * 2000-04-27 2003-02-12 Boehringer Ingelheim Pharma Kg Betamimetika, způsob jejich výroby a použití jako farmaceutický prostředek
US6908928B2 (en) 2000-10-12 2005-06-21 Bi Pharma Kg. Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
PT1292281E (pt) * 2000-10-12 2004-11-30 Boehringer Ingelheim Pharma Novos pos para inalacao contendo tiotropio
DE10050995A1 (de) * 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue Anticholinergika, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
US6706726B2 (en) * 2000-10-14 2004-03-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Anticholinergics which may be used as medicaments as well as processes for preparing them
US6852728B2 (en) 2000-10-14 2005-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Anticholinergics, processes for preparing them, and pharmaceutical compositions containing them
US20020111363A1 (en) * 2000-10-31 2002-08-15 Karin Drechsel Inhalable formulation of a solution containing a tiotropium salt
US20020137764A1 (en) * 2000-10-31 2002-09-26 Karin Drechsel Inhalable formulation of a solution containing a tiotropium salt
US7776315B2 (en) * 2000-10-31 2010-08-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and additional active ingredients
DE10062712A1 (de) * 2000-12-15 2002-06-20 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
US20020151541A1 (en) * 2000-10-31 2002-10-17 Michel Pairet Pharmaceutical compositions containing tiotropium salts and antihistamines and their use
US20020193392A1 (en) * 2000-11-13 2002-12-19 Christel Schmelzer Pharmaceutical compositions based on tiotropium salts of salts of salmeterol
US20100310477A1 (en) * 2000-11-28 2010-12-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg. Pharmaceutical compositions based on anticholingerics and additional active ingredients
US20030013675A1 (en) * 2001-05-25 2003-01-16 Boehringer Ingelheim Pharma Kg Combination of an adenosine A2A-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways and other inflammatory diseases
US20030070679A1 (en) * 2001-06-01 2003-04-17 Boehringer Ingelheim Pharma Kg Capsules containing inhalable tiotropium
US20030018019A1 (en) * 2001-06-23 2003-01-23 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics
DE10141377A1 (de) * 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Aufstreuverfahren zur Herstellung von Pulverformulierungen
US6919325B2 (en) * 2001-09-14 2005-07-19 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions containing tiotropium salts and low-solubility salmeterol salts
DE10200943A1 (de) 2002-01-12 2003-07-24 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Scopinestern
US7405224B2 (en) * 2002-01-31 2008-07-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Xanthenecarboxylates, processes for preparing them, and their use as pharmaceutical compositions
US6790856B2 (en) * 2002-01-31 2004-09-14 Boehringer Ingelheim Pharma Kg Fluorenecarboxylic acid esters, process for the manufacture thereof, and use thereof as medicaments
US20030229227A1 (en) * 2002-03-16 2003-12-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg New difurylglycolic acid esters, processes for the preparation thereof as well as the use thereof as pharmaceutical compositions
US7309707B2 (en) * 2002-03-20 2007-12-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
US7244415B2 (en) * 2002-03-28 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg HFA suspension formulations of an anhydrate
US7311894B2 (en) * 2002-03-28 2007-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg HFA suspension formulations containing an anticholinergic
EP1494648B1 (en) * 2002-04-04 2006-09-20 Boehringer Ingelheim Pharma GmbH & Co.KG Powder formulations suitable for inhalation
US20030235538A1 (en) 2002-04-09 2003-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Method for the administration of an anticholinergic by inhalation
DE10216427A1 (de) * 2002-04-12 2003-10-23 Boehringer Ingelheim Pharma Arzneimittelkompositionen enthaltend heterocyclische Verbindungen und ein neues Anticholinergikum
US7084153B2 (en) * 2002-04-12 2006-08-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments comprising steroids and a novel anticholinergic
US7417051B2 (en) * 2002-04-12 2008-08-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments comprising betamimetics and a novel anticholinergic
US7094788B2 (en) * 2002-04-13 2006-08-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Esters of hydroxyl-substituted nitrogen heterocycles, processes for the preparation thereof as well as the use thereof as pharmaceutical compositions
US7763280B2 (en) * 2002-11-28 2010-07-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing powder formulation for inhalation
DE10345065A1 (de) * 2003-09-26 2005-04-14 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
SE0303570L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Fukt-känslig medicinsk produkt
TWI274641B (en) * 2005-08-30 2007-03-01 Rexon Ind Corp Ltd Cutting machine
USD831375S1 (en) 2017-01-20 2018-10-23 The Gillette Company Llc Shaving razor stand
EP3351138B1 (en) 2017-01-20 2020-09-09 The Gillette Company LLC Personal care product docking system

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3505337A (en) * 1967-12-22 1970-04-07 Boehringer Sohn Ingelheim N - hydrocarbyl-substituted noratropinium,haloalkylates and o-acyl derivatives thereof

Also Published As

Publication number Publication date
FI62083B (fi) 1982-07-30
FI62083C (fi) 1982-11-10
FI762590A (pt) 1977-03-13
JPS625983A (ja) 1987-01-12
BE846104A (fr) 1977-03-10
NL187210B (nl) 1991-02-01
IE44166B1 (en) 1981-08-26
AT353428B (de) 1979-11-12
ATA618676A (de) 1979-04-15
GB1517086A (en) 1978-07-12
DK142988C (da) 1981-10-12
JPS6152155B2 (pt) 1986-11-12
NO763109L (pt) 1977-03-15
PT65571A (de) 1976-10-01
NO145199C (no) 1982-02-03
NL187210C (nl) 1991-07-01
ES451467A1 (es) 1977-11-01
JPS6233232B2 (pt) 1987-07-20
NZ182011A (en) 1978-09-25
IE44166L (en) 1977-03-12
CH621349A5 (pt) 1981-01-30
AU1762976A (en) 1978-03-16
DE2540633A1 (de) 1977-04-28
US4042700A (en) 1977-08-16
AU506286B2 (en) 1979-12-20
JPS5236693A (en) 1977-03-22
FR2323387A1 (fr) 1977-04-08
FR2323387B1 (pt) 1980-10-10
CA1079733A (en) 1980-06-17
SE7610070L (sv) 1977-03-13
SE428472B (sv) 1983-07-04
LU75781A1 (pt) 1978-05-12
DK142988B (da) 1981-03-09
DE2540633C2 (pt) 1989-01-19
DK411576A (da) 1977-03-13
ZA765426B (en) 1978-05-30
MX4053E (es) 1981-11-24
NO145199B (no) 1981-10-26
NL7610063A (nl) 1977-03-15

Similar Documents

Publication Publication Date Title
PT65571B (de) Neue quartare n-beta-substituierte benzilsaure-n-alkyl-nortropinester und verfahren zu deren herstellung
DD132968A5 (de) Neue spirolactone und verfahren zu deren herstellung
ATA800876A (de) Verfahren zur herstellung von neuen 2-phenyl-3- aroylbenzothiophenen und 2-phenyl-3- -aroylbenzothiophen-1-oxiden und von deren salzen
DD128320A5 (de) Quarternaere ammoniumverbindungen und verfahren zu ihrer herstellung
AT358833B (de) Hartmetall und verfahren zu seiner herstellung
AT365088B (de) Keramikfilter und verfahren zu seiner herstellung
PT64977B (de) Neue erythromycinderivate und verfahren zu ihrer herstellung
PT67107A (de) Neue 1-aryloxy-2-hydroxy-3-alkylenaminopropane und verfahren zu ihrer herstellung
PT65980A (de) Basisch substituierte indolderivate und verfahren zu ihrer herstellung
DD129452A5 (de) Neue anthracyclinglycoside und verfahren zu deren herstellung
AT371862B (de) Ozonierte zusammensetzung und verfahren zu deren herstellung
PT69281A (de) Neue antigenderivate und verfahren zu deren herstellung
DD128621A5 (de) Koernige aktivkohle und verfahren zu ihrer herstellung
PT67949B (de) Neue n-/1-(3-benzoylpropil)-4-piperidyl/-sulfonsaureamide und verfahren zu deren herstellung
DD127598A5 (de) Antigene praeparate und verfahren zu ihrer herstellung
ATA811977A (de) Baublock und verfahren zu dessen herstellung
PT65095A (de) Antrachinon-bis-amidine und verfahren zu ihrer herstellung
AT347210B (de) Druckbehaelter und verfahren zu seiner herstellung
PT65498A (de) Schaedlingsbekaempfungsmittel und verfahren zu seiner herstellung
ATA887075A (de) Verbundwerkstoff und verfahren zu seiner herstellung
AT374441B (de) Isolierglas und verfahren zu dessen herstellung
AT356304B (de) Verfahren zur herstellung von neuen n2- arylsulfonyl-l-argininamiden und deren salzen
AT362091B (de) Ueberzogene walze und verfahren zu deren her- stellung
PT65350A (de) 1-methyl-2-(phenyl-oxymethyl)-5-nitroimidazole und verfahren zu ihrer herstellung
PT64922B (de) Azabicycloalkane und verfahren zu ihrer herstellung